Sort   by:  
 Page size 
TranscriptomicsFTC-238/hrTPO/RSK008 treated with thyroid peroxidase-disrupting chemicals
These experiments have systematically assessed the potential utility of transcriptomic endpoints as enhancements to the guaiacol assay. Previously, we demonstrated that benzophenone-2, benzophenone, perfluorooctane sulfonate, bisphenol A bis ether, and vinclozolin decreased TPO activity, and that di...
ORGANISM(S): Homo sapiens 
2011-11-09 | E-GEOD-30961 | biostudies-arrayexpress
TranscriptomicsHuman bronchial cells (BEAS-2B) treated with amiodarone (AM)
AAmiodarone is an antiarrhythmic drug and representatively induce pulmonary phospholipidosis. Amiodarone-induced toxicity has been a serious unpredictable side effect of the treatment and an important clinical problem. Possible causes include allergic, cytotoxic or immunologic reactions to this agen...
ORGANISM(S): Homo sapiens 
2011-01-10 | E-GEOD-20582 | biostudies-arrayexpress
TranscriptomicsTranscription profiling of human bronchial cells(BEAS-2B) treated with methotrexate
Methotrexate (MTX) has been widely used for the treatment of a variety of tumors as well as for inflammatory diseases and rheumatoid arthritis (RA). MTX-induced toxicity has been a serious unpredictable side effect of the treatment and an important clinical problem. Possible causes include allergic,...
ORGANISM(S): Homo sapiens 
2008-12-12 | E-GEOD-9815 | biostudies-arrayexpress
UnknownEnvironmental management strategy in response to COVID-19 in China: Based on text mining of government open information.
Not available
S-EPMC7837070 | biostudies-literature
UnknownSafety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial.
Not available
S-EPMC8213361 | biostudies-literature
UnknownEfficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 lineages circulating in Brazil.
Not available
S-EPMC8494913 | biostudies-literature
UnknownEarly sedation with dexmedetomidine in ventilated critically ill patients and heterogeneity of treatment effect in the SPICE III randomised controlled trial.
Not available
S-EPMC7939103 | biostudies-literature
UnknownSafety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.
Not available
S-EPMC7445431 | biostudies-literature
UnknownSafety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial.
Not available
S-EPMC7674972 | biostudies-literature
UnknownSafety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.
Not available
S-EPMC7723445 | biostudies-literature
Sort   by:  
 Page size